Scientists design new drug to fight malaria
- Details
- Category: Research
A team led by scientists at UC Riverside, UC Irvine, and Yale School of Medicine has now designed a new drug against malaria and identified its mechanism of action.
Bayer Co.Lab Shanghai opens as part of global expansion of life science incubator network
- Details
- Category: Bayer
Paving the way for new treatments
- Details
- Category: Research
Jianlin "Jack" Cheng from Mizzou's College of Engineering and his student, Nabin Giri, have developed a tool called Cryo2Struct that uses artificial intelligence (AI) to build the three-dimensional atomic structure of large protein complexes, work recently published in Nature Communications.
Women still missing out on treatment for their No 1 killer - cardiovascular disease
- Details
- Category: Research
They continue to be underdiagnosed, undertreated, and underrepresented in clinical trials in all areas of cardiovascular disease, says the statement.
Nearly 200 potential mammary carcinogens found in food contact materials: new study highlights regulatory shortcomings
- Details
- Category: Research
FDA approves nasal spray influenza vaccine for self- or caregiver-administration
- Details
- Category: FDA
Triptans more effective than newer, more expensive migraine drugs
- Details
- Category: Research
Triptans work by narrowing blood vessels in the brain and preventing the release of chemicals that cause pain and inflammation.
The findings show that four triptans - eletriptan, rizatriptan, sumatriptan, and zolmitriptan - were better at relieving migraine pain than the recently marketed and more expensive drugs lasmiditan, rimegepant, and ubrogepant, which were comparable to paracetamol and most anti-inflammatory painkillers (NSAIDs).
FDA approves OCREVUS ZUNOVO™ as the first and only twice-a-year 10-minute subcutaneous injection for people with relapsing and progressive multiple sclerosis
- Details
- Category: Roche
Up to one-third of antibody drugs are nonspecific
- Details
- Category: Research
More than 39 million deaths from antibiotic-resistant infections estimated between now and 2050
- Details
- Category: Research
The new study by the Global Research on Antimicrobial Resistance (GRAM) Project is the first global analysis of antimicrobial resistance (AMR) trends over time.
It reveals that more than one million people died each year as a result of AMR between 1990 and 2021.